{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:05:07Z","timestamp":1771484707723,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1991,3,1]],"date-time":"1991-03-01T00:00:00Z","timestamp":667785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[1991,3]]},"DOI":"10.1016\/0006-3223(91)90264-m","type":"journal-article","created":{"date-parts":[[2003,4,24]],"date-time":"2003-04-24T17:39:05Z","timestamp":1051205945000},"page":"418-426","source":"Crossref","is-referenced-by-count":84,"title":["Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder"],"prefix":"10.1016","volume":"29","author":[{"given":"Teresa A.","family":"Pigott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Zohar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne E.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gay N.","family":"Grover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel C.","family":"Zohar-Kadouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0006-3223(91)90264-M_BIB1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archpsyc.1989.01810010025004","article-title":"Clomipramine in obsessive-compulsive disorder: Further evidence for a serotonergic mechanism of action","volume":"46","author":"Benkelfat","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/0006-3223(91)90264-M_BIB2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02253718","article-title":"Involvement of 5-HT1c-receptors in drug-induced penile erections in rats","volume":"101","author":"Berendsen","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/0006-3223(91)90264-M_BIB3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.2042-7158.1981.tb13841.x","article-title":"m-Chlorophenylpiperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone","volume":"34","author":"Caccia","year":"1981","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/0006-3223(91)90264-M_BIB4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archpsyc.1988.01800260095012","article-title":"Serotonin function in obsessive-compulsive disorder: A comparison of the effects of tryptophan and m-CPP in patients and healthy subjects","volume":"45","author":"Charney","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/0006-3223(91)90264-M_BIB5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0165-6147(90)90109-L","article-title":"m-CPP: A tool for studying behavioural responses associated with 5-HT1c receptors","volume":"11","author":"Curzon","year":"1990","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/0006-3223(91)90264-M_BIB6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0165-6147(89)90061-8","article-title":"5-HT1c receptor activation: A key step in the initiation of migraine","volume":"10","author":"Fozard","year":"1989","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/0006-3223(91)90264-M_BIB7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archpsyc.1989.01810010038006","article-title":"Efficacy of fluvoxamine in obsessive-compulsive disorder: A double-blind comparison of fluvoxamine and placebo","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/0006-3223(91)90264-M_BIB8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1176\/ajp.145.8.1015","article-title":"Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: Behavioral findings","volume":"145","author":"Hollander","year":"1988","journal-title":"Am J Psychiatry"},{"key":"10.1016\/0006-3223(91)90264-M_BIB9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10799898809048978","article-title":"Functional correlates of 5-HT1 recognition sites","volume":"8","author":"Hoyer","year":"1988","journal-title":"J Recept Res"},{"key":"10.1016\/0006-3223(91)90264-M_BIB10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1476-5381.1988.tb11508.x","article-title":"Evidence that m-CPP may have behavioral effects mediated by central 5-HT1c receptors","volume":"94","author":"Kennett","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1016\/0006-3223(91)90264-M_BIB11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0014-2999(87)90357-8","article-title":"Antidepressant-like action of 5-HT1a agonists and conventional antidepressants in an animal model of depression","volume":"134","author":"Kennett","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/0006-3223(91)90264-M_BIB12","first-page":"445","volume":"164","author":"Kennett","year":"1989","journal-title":"Anxiogenic-like effects of m-CPP and TFMPP in animal models are opposed by 5-HT1c receptor antagonists"},{"key":"10.1016\/0006-3223(91)90264-M_BIB13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jcem-61-6-1179","article-title":"Neuroendocrine effects of m-CPP, a serotonin agonist in humans","volume":"61","author":"Mueller","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/0006-3223(91)90264-M_BIB14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF00174380","article-title":"Further studies of the putative serotonin agonist, m-CPP: Evidence for a serotonin receptor-mediated mechanism of action in humans","volume":"89","author":"Mueller","year":"1986","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/0006-3223(91)90264-M_BIB15","series-title":"The Behavior of Psychiatric Patients","first-page":"355","article-title":"Methods for the quantitative assessment of depressive and manic behavior","author":"Murphy","year":"1982"},{"key":"10.1016\/0006-3223(91)90264-M_BIB16","first-page":"15","article-title":"Obsessive-compulsive disorder as a 5-HT subsystem-related behavioral disorder","volume":"155","author":"Murphy","year":"1989","journal-title":"Br J Pharmacol"},{"key":"10.1016\/0006-3223(91)90264-M_BIB17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00444705","article-title":"Comparative anxiogenic, neuroendocrine, and other physiological effects of m-CPP given intravenously or orally to healthy volunteers","volume":"98","author":"Murphy","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/0006-3223(91)90264-M_BIB18","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1176\/ajp.144.12.1543","article-title":"Fluvoxamine treatment of obsessive-compulsive disorder","volume":"144","author":"Perse","year":"1987","journal-title":"Am J Psychiatry"},{"key":"10.1016\/0006-3223(91)90264-M_BIB19","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.1990.01810220042005","article-title":"Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder: Behavioral and biological results","author":"Pigott","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/0006-3223(91)90264-M_BIB20","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1096\/fasebj.3.11.2673898","article-title":"5-Hydroxytryptamine receptor families","volume":"3","author":"Schmidt","year":"1989","journal-title":"J FASEB"},{"key":"10.1016\/0006-3223(91)90264-M_BIB21","first-page":"1236","article-title":"5-HT function in the biochemical and behavioral responses to m-CPP in healthy subjects and schizophrenics (Abstract)","volume":"15","author":"Seibyl","year":"1989","journal-title":"Soc Neurosci"},{"key":"10.1016\/0006-3223(91)90264-M_BIB22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archpsyc.1980.01780240079009","article-title":"Clomipramine treatment of obsessive-compulsive disorder: I. A controlled clinical trial","volume":"37","author":"Thoren","year":"1980","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/0006-3223(91)90264-M_BIB23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00004714-198508000-00003","article-title":"Fluoxetine treatment of obsessive-compulsive disorder","volume":"5","author":"Turner","year":"1985","journal-title":"J Clin Psychopharm"},{"key":"10.1016\/0006-3223(91)90264-M_BIB24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF02245806","article-title":"Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (m-CPP) into the hippocampus","volume":"100","author":"Whitton","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/0006-3223(91)90264-M_BIB25","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archpsyc.1987.01800230026006","article-title":"Serotonergic responsivity in obsessive-compulsive disorder: Comparison of patients and healthy controls","volume":"44","author":"Zohar","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/0006-3223(91)90264-M_BIB26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archpsyc.1988.01800260081011","article-title":"Serotonergic responsivity in obsessive-compulsive disorder: Effects of chronic clomipramine treatment","volume":"45","author":"Zohar","year":"1988","journal-title":"Arch Gen Psychiatry"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:000632239190264M?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:000632239190264M?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T19:58:55Z","timestamp":1553371135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/000632239190264M"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,3]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1991,3]]}},"alternative-id":["000632239190264M"],"URL":"https:\/\/doi.org\/10.1016\/0006-3223(91)90264-m","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[1991,3]]}}}